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Background: Ontologies are useful in many branches of biomedical research. For instance, in the vaccine domain,
the community-based Vaccine Ontology (VO) has been widely used to promote vaccine data standardization,
integration, and computer-assisted reasoning. However, a major challenge in the VO has been to construct
ontologies of vaccine functions, given incomplete vaccine knowledge and inconsistencies in how this knowledge
is manually curated.
Results: In this study, we show that network-based analysis of vaccine-related networks can identify underlying
structural information consistent with that captured by the VO, and commonalities in the vaccine adverse events
for vaccines and for diseases to produce new hypotheses about pathomechanisms involving the vaccine and the
disease status. First, a vaccine-vaccine network was inferred by applying a bipartite network projection strategy to the
vaccine-disease network extracted from the Semantic MEDLINE database. In total, 76 vaccines and 573 relationships
were identified to construct the vaccine network. The shortest paths between all pairs of vaccines were calculated
within the vaccine network. The correlation between the shortest paths of vaccine pairs and their semantic similarities
in the VO was then investigated. Second, a vaccine-gene network was also constructed. In this network, 4 genes were
identified as hubs interacting with at least 3 vaccines, and 4 vaccines were identified as hubs associated with at least 3
genes. These findings correlate with existing knowledge and provide new hypotheses in the fundamental interaction
mechanisms involving vaccines, diseases, and genes.
Conclusions: In this study, we demonstrated that a combinatorial analysis using a literature knowledgebase, semantic
technology, and ontology is able to reveal important unidentified knowledge critical to biomedical research and public
health and to generate testable hypotheses for future experimental verification. As the associations from Semantic
MEDLINE remain incomplete, we expect to extend this work by (1) integrating additional association databases to
complement Semantic MEDLINE knowledge, (2) extending the neighbor genes of vaccine-associated genes, and
(3) assigning confidence weights to different types of associations or associations from different sources.Background
Vaccines have been one of the most successful public
health interventions to date, with most vaccine-preventable
diseases having declined in the United States by 95% to
99% [1]. However, vaccine development has become more
difficult as more complex organisms become vaccine
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reproduction in any medium, provided the orrapidly and achieved a number of successes for existing
drugs, such as sildenafil [2] and thalidomide [3]. By
definition, drug repositioning is the “process of finding
new uses outside the scope of the original medical
indications for existing drugs or compounds” [4]. In
2009, more than 30% of 51 new medicines and vaccines
were developed on the basis of previously marketed
products. This suggests that drug repositioning has
drawn great attention from both industry and academic
institutions [5]. However, many drug repositioning
examples were based on serendipitous discoveries [6]
or on observable clinical phenotypes, without systematicLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that bioinformatics-based approaches can aid in reposi-
tioning drugs based on the complex relationships among
drugs, diseases, and genes [7].
In recent years, high-throughput biological data
and computational systems biology approaches have
provided an unprecedented opportunity to understand
disease etiology and its underlying cellular subsystems.
Biological knowledge, such as drug-disease networks
and biomedical ontologies, have accelerated the devel-
opment of network-based approaches to understanding
disease etiologies [8,9] and drug actions (network
pharmacology) [10,11]. Such approaches could also be
applied to vaccine research, aiming to investigate vaccine-
related associations derived from public knowledgebases,
such as PubMed. For example, Vaccine Ontology (VO)–
based literature mining research last year studied all
potential gene interactions associated with fever alone
or both fever and vaccine [12]. This study focused on
the retrieval of gene-gene associations identified on the
basis of their direct interactions in the context of fever
and vaccine. The centrality-based network approach
[13] evaluated the level of importance for each gene in
the extracted gene interaction network. Novel gene
interactions were identified to be essential in fever- or
vaccine-related networks that could not be found before.
A similar VO and centrality-based literature mining
approach was used to analyze a vaccine-associated
interferon γ gene interaction network [14].
Ball et al. [15] compiled a network consisting of 6,428
nodes (74 vaccines and 6,354 adverse events) and more
than 1.4 million interlinkages, derived from the Vaccine
Adverse Event Reporting System. This network demon-
strated a scale-free property, in which certain vaccines
and adverse events acted as “hubs.” Such network analysis
approaches complement current statistical techniques
by offering a novel way to visualize and evaluate vaccine
adverse event data. However, the relationships among
different vaccines in the context of vaccine-vaccine and
vaccine-gene networks have not been well studied. A
systematic investigation of such relationships will improve
understanding of how vaccines are related to each other
and whether such information can complement existing
knowledge, such as the VO, therefore providing possible
directions for future drug-repositioning.
To analyze the possible commonly shared protective
immunity or adverse event mechanisms among different
vaccines, it is critical to study all possible vaccine-vaccine
and vaccine-gene associations using network analysis
approaches. The hypotheses behind this are 2-fold: (1)
if 2 vaccines have a coupling relationship with common
disease(s) or gene(s), they are linked in the vaccine
network; and (2) the closer 2 vaccines are in the vaccine
network, the more similar they are in the context of aliterature knowledgebase, such as Semantic MEDLINE
[16]. In this study, we proposed a network-based approach
to investigate the underlying relationships among vaccines
in the context of the vaccine-related network derived
from Semantic MEDLINE. The distances of the vaccines
were further compared with their semantic similarities
in the VO. The results demonstrated that the structure
information in the vaccine network is consistent with
that captured by the VO. Such network-based analysis
can serve as an independent data resource to construct
and evaluate biomedical ontologies. In addition, the
vaccine-gene network was constructed also on the basis
of Semantic MEDLINE information, in which important
vaccine-related genes were identified and investigated by
the VO and related independent resources. Both analyses
demonstrated the potential to serve as the basis for future
drug discovery and repositioning. The results of this
study will establish associations that may kindle hypothesis
generation about drug repositioning.
The rest of the paper is organized as follows. Section 2
introduces the data resources and the proposed network-
based framework. Section 3 illustrates the results gen-
erated from each step in the proposed computational
framework. Section 4 provides a thorough discussion of
the results and concludes the paper.Materials and methods
In this section, we first describe the data resources and
preprocessing method in this work. We then introduce
our proposed network-based approach for investigating
vaccine-related associations derived from literature
abstracts in PubMed. The evaluation of the discovered
vaccine-vaccine and vaccine-gene relationships is based
on the VO hierarchy and logical definitions. Figure 1
illustrates the steps of the proposed approach.Data sources and preprocessing
Data resources
In this study, we used Semantic MEDLINE as the data
resource to build the networks. Semantic MEDLINE [16]
is a National Library of Medicine–initiated project, which
provides a publicly available database that contains
comprehensive resources, with structured annotations
for information extracted from more than 19 million
MEDLINE abstracts. Since Semantic MEDLINE is a
comprehensive resource that contains heterogeneous data
with different features extracted, our previous research
has reorganized this data source and optimized it for
informatics analysis [17]. Using the Unified Medical
Language System semantic types and groups [18], we
extracted unique associations among diseases, genes, and
drugs and represented them in 6 Resource Description
Framework (RDF) graphs. In this study, we used our
Figure 1 Overview of the proposed framework. The proposed method consists of 3 steps: (1) extraction of vaccine-related associations from
Semantic MEDLINE using ontology-based terms; (2) network-based analyses to identify vaccine-vaccine associations and vaccine-gene associations;
and (3) evaluation of inferred vaccine-vaccine and vaccine-gene relationships using VO hierarchical structure and literature validation.
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source to perform network analysis for vaccine-related
networks.
Our RDF-based Semantic MEDLINE resource currently
contains 843,000 disease-disease, 111,000 disease-gene,
1,277,000 disease-drug, 248,000 drug-gene, 1,900,000
drug-drug, and 49,000 gene-gene associations. Since
this resource contains high-level terms (eg, gene, protein,
disease) that are not useful for network analysis, we
manually filtered out these terms. For disease terms, we
used only those terms that are included in International
Classification of Diseases, Ninth Revision (ICD 9). For
gene terms, we included only those terms that have an
Entrez Gene ID.
Data extraction
We identified the associations relevant to vaccines only.
Specifically, vaccine terms were identified on the basis of
Systematized Nomenclature of Medicine–Clinical Terms
(SNOMED CT) (http://www.ihtsdo.org/snomed-ct). All
the terms under the SNOMED CT term Vaccine (CUI:
C0042210) were first extracted. Manual review by 3 experts
further removed common terms (eg, bacteria, vaccine) and
animal vaccine terms.
Network analysis of vaccine network
Projection of bipartite vaccine-disease network
In graph theory, a bipartite network is composed of 2
non-overlapping sets of nodes and links that connect 1
node in the first node set with 1 node in the second
node set. The properties of bipartite networks are often
investigated by considering the 1-mode projection of the
bipartite network. The 1-mode projection network can
be created by connecting 2 nodes in the same node set
if they have at least 1 common neighboring node in
the other node set. For instance, the vaccine-disease
association network is 1 bipartite network: vaccines and
diseases constitute 2 node sets, and links are generated
between vaccine and disease if they are associated inthe Semantic MEDLINE. Therefore, the vaccine-vaccine
network can be investigated by projecting vaccine-disease
associations to vaccine-vaccine associations, in which 2
vaccines are connected if they are associated with at
least 1 same disease. In this work, all links were generated
on the basis of associations extracted from Semantic
MEDLINE as described in the preceding section, “Data
Sources and Preprocessing.” A vaccine-vaccine network
was generated consisting of all the links identified in
vaccine-disease associations.
Network distance between vaccines
The distance between any two vaccines in the vaccine
network was calculated as the length of the shortest path
between them [19]. The hierarchical clustering analysis
was performed on the distance matrix of all vaccines
[20]. Compared to other clustering methods (e.g., k-mean
clustering), hhierarchical clustering doesn’t need specify
the number of clusters in advance, generates small clusters
that are more biologically meaningful, and produces a
bottom-up hierarchical structure that is indicative of
similarities among variables.
A heatmap is an effective way to visually display multi-
variate data, which combines the use of color to distin-
guish the magnitude of measurements and dendrograms
to show clustering of variables [21]. Heatmaps are often
used for gene expression data to identify the similairty
among genes or samples. In this study, we used heatmaps
to investigate the hierarchical associations among vaccine
terms.
Analysis of vaccine-gene network
The vaccine-gene network was constructed by vaccine-
gene associations extracted from the drug-gene associa-
tions in our RDF-based data resource. The important
vaccine-related genes were identified by their significant
higher node degree compared with other vaccines or
genes in the same network. The Cytoscape tool [22] was
used to visualize the network. Cytoscape is an open-source
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biological networks. Its functionalities can be extended
through Cytoscape plugins. Scientists from different re-
search fields have contributed more than 160 useful
plugins so far. These comprehensive features allow us to
perform thorough network-level analyses, visualization
of our association tables, and integration with other
biological networks in the future.
Analysis of vaccine groups using VO
The community-based VO includes more than 4,000
vaccine-specific terms, namely, all licensed human and
veterinary vaccines currently used in the United States.
Logical axioms have been defined in the VO to represent
the relations among vaccine terms [14]. The Semantic
MEDLINE analysis uses SNOMED terms to represent
various vaccines. The VO has established automatic
mapping between SNOMED vaccine terms and VO
terms. On the basis of the mapping, we first extracted
all vaccine terms from the Semantic MEDLINE and
mapped to the VO. The ontology term retrieval tool
OntoFox [23] was then applied to obtain the hierarchies
of the total vaccines or subgroups of the vaccines iden-
tified in this study.
Results
The overall network view
In total, 76 vaccines, annotated by the SNOMED CT
term Vaccine (CUI: C0042210), were used to extract
related vaccine-disease and vaccine-gene associations
from the drug-disease and drug-gene association tables,
respectively. In the vaccine-disease network, there
were 1,038 nodes (104 vaccines and 934 diseases) and
1,693 vaccine-disease associations (Additional file 1).
In the vaccine-gene network, there were 170 nodes (85
vaccines and 85 genes) (Additional file 2) and 94
vaccine-gene associations. One vaccine network was
generated by the projection of the vaccine-disease
bipartite network, consisting of 76 vaccines and 573
associations (Additional file 3). This vaccine network
was then used to analyze the vaccine relationships. The
derived vaccine-gene network was also investigated by
the VO knowledge.
Analysis of vaccine network
Figure 2 shows a heat map of hierarchical analysis results,
providing direct visualization of potential vaccine-vaccine
associations. Here we selected 4 relatively large vaccine-
vaccine association groups on the diagonal from Figure 2
and explain them in detail:
Vaccine-vaccine association 1
This group contains 18 widely studied vaccines. Many
interesting results have been obtained from the analysisof this group of vaccine-disease-vaccine associations.
For example, the results from this group show that
influenza vaccines and rabies vaccines have been asso-
ciated with the induction of a severe adverse event,
Guillain-Barré syndrome [24,25]. Guillain-Barré syndrome
is a rare disorder in which a person’s own immune system
damages the nerve cells, causing muscle weakness and
sometimes paralysis. This group also includes 5 other
vaccines associated with nervous system disorders, includ-
ing pertussis vaccine [26], diphtheria and tetanus toxoids
and pertussis (DTP) vaccine [27], hepatitis B vaccine [28],
chickenpox vaccine [29], and poliovirus vaccine [30,31].
As shown by a VO hierarchical structure layout (Figure 3),
these 7 vaccines belong to different bacterial and viral
vaccine groups. For instance, the DTP vaccine is a
combination vaccine that contains 3 individual vaccine
components, including a pertussis vaccine. DTP is asserted
in the VO as a subclass of diphtheria and tetanus toxoids
vaccine. In SNOMED, DTP is asserted as subclass of a
“Diphteria + tetanus vaccine”, which is a subclass of
‘tetanus vaccine’ and ‘diphtheria vaccine’. However, the
DTP term in SNOMED does not include any axiom
that makes the association of the vaccine to any of the
pathogens that causes the three diseases. Different from
SNOMED, the VO logically defines vaccines by associating
each vaccine to the pathogen organisms defined in the
NCBI Taxonomy Ontology. For example, a VO vaccine
for diphtheria has the following axiom definition: ‘vaccine
immunization against microbe’ some ‘Corynebacterium
diphtheriae’. This logical definition links the VO vaccine
to the bacterium ‘Corynebacterium diphtheriae’ defined in
the NCBOTaxon ontology with the ID: NCBITaxon_1717.
Since multiple inheritances are not used in the VO, an
inference applying an ontology reasoner was used to
infer that the DTP is also Bordetella pertussis vaccine
(ie, pertussis vaccine) (Figure 3). It is likely that the
association of the combination vaccine DTP with a
neurologic disorder is at least partially attributable to
the pertussis vaccine component.
Our study also identified many other diseases associated
with different vaccines. For example, 5 vaccines (eg,
pertussis vaccine) were found to be associated with various
types of antimicrobial susceptibility, and 8 vaccines
(eg, influenza vaccine) have been co-studied in patients
with the asthma condition. Because of the relatively
poor annotation of the vaccine data in the Semantic
MEDLINE system, the vaccines identified in the se-
mantic analysis were poorly classified. Our previous
study [32] also confirmed that the vaccine annotations
in VO are more granular than that in Semantic MED-
LINE or MeSH. The incorporation of the VO in the
study clearly classifies these vaccines, leading to better
understanding of the result of the Semantic MEDLINE
analysis.
Figure 2 The heat map of vaccine-vaccine associations. The shortest path matrix of all vaccine pairs was used to generate the heat map.
Each row (column) represents a vaccine term. The color scale represents the shortest path between any vaccine pair.
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This group of vaccines, including Q fever vaccine, parvo-
virus vaccine, and tick-borne encephalitis vaccine, is asso-
ciated with the common disease delayed hypersensitivity.
Delayed-type reactions may occur at days after vaccination
and often raise serious safety concerns. Delayed hypersen-
sitivity is not antibody mediated but rather is a type ofFigure 3 The VO hierarchical structure of the seven vaccines
associating with neurological disorder. A reasoning process
assigned the Diphtheria-Tetanus-Pertussis vaccine under Bordetella
pertussis vaccine. The Protégé-OWL editor 4.2 was used for the
figure generation.cell-mediated response. The study of common vaccines
and gene and pathway features related to the delayed
reaction will help to reveal the cause of a delayed-type
reaction and eventually prevent it. While these vaccines
are developed against different bacterial or viral diseases,
there may be similarities among the vaccines, such as
common vaccine ingredients (eg, adjuvant) and a shared
target in some common biological pathway in human.
Identification of these common features may indicate a
common cause of a delayed-type reaction.
Vaccine-vaccine association 3
This group of vaccines is associated with the common
disease mumps. The vaccines in this group include mumps
vaccine, measles, mumps, rubella, and varicella virus
vaccine, and DTP-Haemophilus b conjugate vaccine
(DTP-Hib). The first 2 vaccines protect against mumps.
The DTP-Hib vaccine was compared with a mumps
vaccine in a study [33].
Vaccine-vaccine association 4
This vaccine group consists of 7 vaccines (eg, Brucella
abortus vaccine and bovine rhinotracheitis vaccine) with
direct associations between them. They are all associated
with the common term calf in the literature abstracts.
Since calf disease is a synonym Scheuermann disease,
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disease because of the ambiguity of the Natural Language
Processing (NLP) process. This ambiguity can be improved
by future advancement in the disambiguity capacity of
the NLP tools.
Vaccine-gene network
In the vaccine-gene network (Additional file 4), many
genes were found to interact with different vaccines.
Four genes (TH1L, CD40LG, TFPI, and CD79A) have
been identified as interacting with at least 3 vaccines.
These 4 genes can be considered hub genes in the
vaccine-gene network. Among them, CD40LG (CD40
ligand) is closely associated with 5 vaccines: diphtheria
toxoid vaccine, cholera vaccine, tetanus toxoid vaccine,
chickenpox vaccine, and inactivated poliovirus vaccine
(Figure 4). CD40LG plays an important role in antigen
presentation and stimulation of cytotoxic T lymphocytes
[34]. CD40LG can also be used in rational vaccine adju-
vant design [35]. It is likely that all 5 of these vaccines
stimulate protective immunity through the same CD40LG-
mediated pathway. Our finding confirms the important
role of CD40LG and provides a possible hypothesis on
how different bacterial and viral vaccines stimulate a
protective immune response in the host. Another example
is CD79A (immunoglobulin-associated alpha, also known
as mb-1), a phosphoprotein that is a component of the
CD79a/CD79b dimer associated with membrane-bound
immunoglobulin in B cells. This dimer interacts with
the B-cell antigen receptor and enables the cell to respondFigure 4 A vaccine-gene subnetwork. The associations between vaccine
Rectangular purple nodes represent vaccines, and round yellow nodes repto the antigens on the cell surface [36]. The presence of
the CD79a suggests strong B-cell–mediated antibody
response. Interestingly, both CD40LG and CD79A interact
with the same inactivated poliovirus vaccine. It is likely
that the inactivated poliovirus vaccine induces both
CD40LG-mediated cellular immune response and CD79A-
mediated B-cell antibody response.
In the gene-vaccine network, many vaccines also inter-
act with multiple genes. Four vaccines (diphtheria toxoid
vaccine, DTP vaccine, inactivated poliovirus vaccine,
and influenza virus vaccine) were found to interact with
at least 3 genes. According to the VO, diphtheria toxoid
vaccine protects against infection by Corynebacterium
diphtheriae. In addition to C diphtheriae, the DTP vaccine
also protects against infection by Clostridium tenani
and Bordetella pertussis. Both of these vaccines interact
with CD40LG and TH1L. So it is likely that these 2 pro-
teins specifically interact with the same C diphtheriae
component in diphtheria toxoid vaccine, but not with
the other components in the DTP vaccine.
Conclusions and future work
In this paper, we proposed a novel network-based ap-
proach to investigate vaccine relationships in the context
of a vaccine network extracted from abstracts from
the literature posted to PubMed. These investigations
of vaccine-vaccine, vaccine-disease, and vaccine-gene
networks demonstrated that such literature-based as-
sociations can be better analyzed using the VO and
such a combinatorial analysis is able to reveal thes and related genes were visualized by the Cytoscape tool [22].
resent genes.
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vaccine-vaccine associations based on vaccine-disease
distance analysis were consistent with their VO categories
and often lead to the generation of new hypotheses.
Our studies identified some novel vaccine-vaccine rela-
tionships by discovering a group of vaccines associated
with some common diseases, as demonstrated in the heat
map analysis in the Results section. Because information
in the literature is incomplete, such vaccine-vaccine
associations need further validation in independent
databases or through future experimental studies. For
example, while our analysis revealed associations between
a group of vaccines and neurologic adverse events, the
evidence of these associations, although reported by some
PubMed abstracts, has not necessarily been commonly
acknowledged [37]. More analysis may be required for
clarification. As such relationships are further validated
by independent data resource such as Electronic Health
Record (EHR), they can complement current relationships
in VO and provide additional underlying targets for
vaccine repositioning in the future.
Extensions of this work include the following: (1) inte-
gration of more comprehensive vaccine-disease associ-
ation databases (e.g., the Vaccine Adverse Event Reporting
System) to construct more complete vaccine-related
networks; (2) generation of a vaccine-related gene network
by extending analysis to the neighbor genes of vaccine-
associated genes; (3) network-based investigation of the
relationships among vaccines and other drugs using
vaccine-drug associations; and (4) investigation of pos-
sible ways to improve the network by assigning metrics
such as weights or confidence rates to different types of
associations or associations from different sources.
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